Rigshospitalet, Denmark
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Rigshospitalet, Denmark sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Rigshospitalet, Denmark: 4 sponsored US clinical trials, none currently recruiting.
Rigshospitalet, Denmark sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Chronic Myelomonocytic Leukemia-1, with 1 trials.
Upper-quartile sponsor footprint
Rigshospitalet, Denmark sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
NCT03682029
NA-AION Risk Factors: New Perspectives
NCT05305079
Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography
NCT02011061
Hypothermia to Prevent High Intracranial Pressure in Patients With Acute Liver Failure
NCT00670124
Therapeutic Areas
How the Rigshospitalet, Denmark archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Chronic Myelomonocytic Leukemia-1 (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Rigshospitalet, Denmark: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Rigshospitalet, Denmark sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Rigshospitalet, Denmark page
4 registered trials is a research-attention snapshot, not an endorsement of Rigshospitalet, Denmark or any single study.
- None of Rigshospitalet, Denmark's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Chronic Myelomonocytic Leukemia-1 is the condition Rigshospitalet, Denmark studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Myelomonocytic Leukemia-1 trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rigshospitalet, Denmark pipeline card: 4 registered trials from official public datasets.Report a data error.